A Forward-Thinking Approach to Addressing the New Synthetic Opioid 2-Benzylbenzimidazole Nitazene Analogs by Liquid Chromatography–Tandem Quadrupole Mass Spectrometry (LC–QQQ-MS)
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Novel psychoactive substances (NPS) continue to represent a threat to public health and safety. The number of new drugs in the latest emergent synthetic opioid class—the 2-benzylbenzimidazole analogs—also called the nitazenes—has begun to dominate the current new synthetic opioid (NSO) subclass of NPS. We describe a liquid chromatography–tandem quadrupole mass spectrometry method for the quantification of nine analogs and/or metabolites of drugs in this series: isotonitazene, metonitazene, protonitazene, etonitazene, clonitazene, flunitazene, N-desethyl isotonitazene, 5-amino isotonitazene and 4ʹ-hydroxy nitazene in human whole blood, urine, and tissue. Samples were prepared for analysis using a basic liquid–liquid extraction. Chromatographic separation was achieved using a C-18 analytical column. Multiple reaction monitoring mode was used for detection. The calibration range for the analytes was 0.5–50 ng/mL (except for 5-amino isotonitazene, which was 1.0–50 ng/mL). The limit of detection was 0.1 ng/mL, and the limit of quantitation was 0.5 ng/mL. The method had no carryover or interferences. Ionization enhancement was observed but did not affect quantitation. All analytes passed the method validation assessment. Authentic human samples suspected of containing NSOs were obtained from a medical examiner and coroner offices, as well as partnering forensic toxicology laboratories. Isotonitazene was confirmed in 92 blood samples, and its metabolites were confirmed across various matrices. Metonitazene (n = 35), flunitazene (n = 5), protonitazene (n = 3), etodesnitazene (n = 2) and butonitazene (n = 1) were also detected in cases. These newly emerging 2-benzylbenzimidazole analogs were commonly found in combination with NPS benzodiazepines and opioids (e.g., flualprazolam, fentanyl). Nitazene analogs are potent esoteric drugs that may not be identified during routine toxicological screening, and specialized assays based on sensitive instrumentation are needed to accurately characterize these NSOs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, the expected high in vivo potency of certain piperidine benzimidazolones stresses the need for highly sensitive analytical instrumentation for their detection (Walton et al., 2021).”
From Elucidating the harm potential of brorphine analogues as new synthetic opioids: Synthesis, in vitro, and in vivo characterization (2024) · cites this paper as Walton et al., 2021
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since then, additional analogs including metonitazene, protonitazene, etonitazene, and etodesnitazene have been reported in forensic, toxicology, and drug checking settings [14].”
From Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs (2026) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The structural differences in these analogs matter clinically because small chemical modifications alter potency, metabolism, and the ability of routine toxicology screenings to detect exposure [14].”
From Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs (2026) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“of nitazene tools confirm that while immunoassays may function as a screening method, they will not replace confirmatory mass spectrometry at the moment because of the inconsistent sensitivity and specificity [14].”
From Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs (2026) · cites this paper as [14]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mattson, C. L., Tanz, L. J., Quinn, K., Kariisa, M., Patel, P., & Davis, N. L. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7006a4 · Cited by 1,063 · cited 6×
“In the USA, isotonitazene was reported in many states across the East and Midwest, including Illinois, Indiana, Ohio and Wisconsin (13, 14).”
BackgroundInfluentialVandeputte, M. M., Van Uytfanghe, K., Layle, N. K., St. Germaine, D. M., Iula, D. M., & Stove, C. P. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00064 · Cited by 161
Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework
Krotulski, A. J., Papsun, D. M., Kacinko, S. L., & Logan, B. K. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa016 · Cited by 146 · cited 3×
“by examining in vivo metabolism following the ingestion of isotonitazene based on the presence of the parent drug (Figure 1) (10).”
BackgroundSelf-citationBlanckaert, P., Cannaert, A., Van Uytfanghe, K., Hulpia, F., Deconinck, E., Van Calenbergh, S., & Stove, C. (2020) · Drug Testing and Analysis · doi:10.1002/dta.2738 · Cited by 116
Synthese basisch substituierter, analgetisch wirksamer Benzimidazol-Derivate
Hunger, A., Kebrle, J., Rossi, A., & Hoffmann, K. J. (1957) · Cellular and Molecular Life Sciences · doi:10.1007/bf02161116 · Cited by 103 · cited 1×
“Isotonitazene is a structural analog of etonitazene, a potential therapeutic agent first synthesized in 1957 as an analgesic; however, etonitazene was never clinically approved for use in humans (6, 7).”
BackgroundKrotulski, A. J., Papsun, D. M., Walton, S. E., & Logan, B. K. (2021) · Drug Testing and Analysis · doi:10.1002/dta.3115 · Cited by 91 · cited 1×
“, butonitazene, etodesnitazene) were screened by liquid chromatography quadrupole time-of-flight mass spectrometry (LC–QTOF-MS) and subsequently quantitated using standard addition with analysis by LC–QQQ-MS, after verification of the standard addition process for each drug (24).”
MethodSelf-citationKrotulski, A. J., Papsun, D. M., Noble, C., Kacinko, S. L., & Logan, B. K. (2021) · Journal of Forensic Sciences · doi:10.1111/1556-4029.14623 · Cited by 47 · cited 8×
“In the USA, isotonitazene was reported in many states across the East and Midwest, including Illinois, Indiana, Ohio and Wisconsin (13, 14).”
BackgroundSelf-citationFlualprazolam Blood Concentrations in 197 Forensic Investigation Cases
Papsun, D. M., Krotulski, A. J., Homan, J., Temporal, K. D. H., & Logan, B. K. (2021) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa070 · Cited by 46 · cited 1×
“forensic toxicology casework screened via mass spectrometry per month) (11, 12).”
BackgroundSelf-citationEmerging Characteristics of Isotonitazene-Involved Overdose Deaths: A Case-Control Study
Shover, C. L., Falasinnu, T. O., Freedman, R. B., & Humphreys, K. (2021) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000775 · Cited by 37 · cited 2×
“The authors of this manuscript would like to acknowledge the following individuals for their contributions to the project: Donna Papsun and Kyle Miller from NMS Labs; Eric Lavins and Szabi Sofalvi from Cuyahoga CountyMedical Examiner’s Office; Amy Miles and Aaron Zane from the Wisconsin State Lab of Hygiene; and Judit…”
Background
Research works printed but not linked: 3
- Krotulski A.J., Papsun D.M., Kacinko S.L., Logan B.K. (2020) Isotonitazene quantitation and metabolite discovery in authentic forensic casework. Journal of Analytical Toxicology, 44, 521– 530. 32091095 · DOI · Paper page
- The Woods at Parkside. (2021) Isotonitazene Found in Growing Ohio Overdose Deaths. Woods at Parkside. https://www.thewoodsatparkside.com/isotonitazene-found-in-growing-ohio-overdose-deaths/ (accessed Mar 8, 2021).
- Controlled Substances - Alphabetical Order Alphabetical Order.
Cited by
Old Drugs and New Challenges: A Narrative Review of Nitazenes
Pergolizzi Jr, J., Raffa, R., LeQuang, J. A. K., Breve, F., & Varrassi, G. (2023) · Cureus · doi:10.7759/cureus.40736 · Cited by 81
“There is scant information on the pharmacokinetics and pharmacodynamics of the street nitazenes [14].”
Schumann, J. L., Syrjanen, R., Alford, K., Mashetty, S., Castle, J. W., Rotella, J., Maplesden, J., & Greene, S. L. (2023) · Journal of Analytical Toxicology · doi:10.1093/jat/bkac062 · Cited by 61
De Vrieze, L. M., Walton, S. E., Pottie, E., Papsun, D., Logan, B. K., Krotulski, A. J., Stove, C. P., & Vandeputte, M. M. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03774-7 · Cited by 58
“OH nitazene is a universal metabolite of all nitazenes with alkoxy chain modifications only (Taoussi et al. 2024; Kanamori et al. 2024; Walton et al. 2021).”
BackgroundSelf-citationNon-Fentanyl New Synthetic Opioids—An Update
Zawilska, J. B., Adamowicz, P., Kurpeta, M., & Wojcieszak, J. (2023) · Forensic Science International · doi:10.1016/j.forsciint.2023.111775 · Cited by 55
Mu-Opioid Receptor Selective Superagonists Produce Prolonged Respiratory Depression
Malcolm, N. J., Palkovic, B., Sprague, D. J., Calkins, M. M., Lanham, J. K., Halberstadt, A. L., Stucke, A. G., & McCorvy, J. D. (2023) · iScience · doi:10.1016/j.isci.2023.107121 · Cited by 53
“The extent to which nitazenes undergoN-deethylation after in vivo administration is not clear, but in a published analysis of samples collected during toxicology casework,N-desethyl isotonitazene and isotonitazene were detected in blood samples at similar concentrations.(55) If the N-deethylation of nitazenes does occ…”
BackgroundVandeputte, M. M., Verougstraete, N., Walther, D., Glatfelter, G. C., Malfliet, J., Baumann, M. H., Verstraete, A. G., & Stove, C. P. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03294-2 · Cited by 44
Vandeputte, M. M., Tsai, M.-H. M., Chen, L., Glatfelter, G. C., Walther, D., Stove, C. P., Shi, L., & Baumann, M. H. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109939 · Cited by 39
Palmquist, K. B., Truver, M. T., Shoff, E. N., Krotulski, A. J., & Swortwood, M. J. (2023) · Journal of Forensic Sciences · doi:10.1111/1556-4029.15282 · Cited by 39
Self-citationPucci, M., Singh Jutley, G., Looms, J., & Ford, L. (2024) · Clinical Toxicology · doi:10.1080/15563650.2024.2309321 · Cited by 37
Schüller, M., Lucic, I., Øiestad, Å. M. L., Pedersen-Bjergaard, S., & Øiestad, E. L. (2023) · Journal of Analytical Toxicology · doi:10.1093/jat/bkad071 · Cited by 37
“Ion enhancement for nitazenes with LC–ESI-MS analysis has also been observed in the literature (15).”
MethodVandeputte, M. M., & Stove, C. P. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110470 · Cited by 36
Walton, S. E., Krotulski, A. J., Glatfelter, G. C., Walther, D., Logan, B. K., & Baumann, M. H. (2023) · Psychopharmacology · doi:10.1007/s00213-022-06292-5 · Cited by 33
Self-citationNitazenes: review of comparative pharmacology and antagonist action
Stangeland, M., Dale, O., & Skulberg, A. K. (2025) · Clinical Toxicology · doi:10.1080/15563650.2025.2504133 · Cited by 34
Ververi, C., Galletto, M., Massano, M., Alladio, E., Vincenti, M., & Salomone, A. (2024) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2024.115975 · Cited by 34
Pardi, J., Ford, S., & Cooper, G. (2023) · Journal of Analytical Toxicology · doi:10.1093/jat/bkad062 · Cited by 29
Calello, D. P., Aldy, K., Jefri, M., Nguyen, T.-A. T., Krotulski, A., Logan, B., Brent, J., Wax, P., Walton, S., Manini, A. F., et al. (2022) · Clinical Toxicology · doi:10.1080/15563650.2022.2084406 · Cited by 26
Self-citationAmeline, A., Gheddar, L., Pichini, S., Stove, C., Aknouche, F., Maruejouls, C., Raul, J.-S., & Kintz, P. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119764 · Cited by 26
Advances in analytical methodologies for detecting novel psychoactive substances: a review
Krotulski, A. J., Mata, D. C., Smith, C. R., Palmquist, K. B., Modell, C., Vikingsson, S., & Truver, M. T. (2024) · Journal of Analytical Toxicology · doi:10.1093/jat/bkae098 · Cited by 30
Self-citationMurari, M., Pesavento, S., Greco, F., Vettori, A., Tagliaro, F., & Gottardo, R. (2024) · Drug Testing and Analysis · doi:10.1002/dta.3590 · Cited by 21
Parks, C., Maskell, P., McKeown, D. A., & Couchman, L. (2024) · Journal of Analytical Toxicology · doi:10.1093/jat/bkae076 · Cited by 23
Synthetic Benzimidazole Opioids: The Emerging Health Challenge for European Drug Users
Di Trana, A., Pichini, S., Pacifici, R., Giorgetti, R., & Busardò, F. P. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.858234 · Cited by 18
“Currently, other analogs such as flunitazene, butonitazene, etodesnitazene, protonitazene, etonitazepyne, and metodesnitazene have been disclosed in the illicit western markets, but related fatal cases or intoxications have not yet been documented (20).”
BackgroundStructural Characterization of Nitazene Analogs Using Electron Ionization-Mass Spectrometry (EI-MS)
Hardwick, E. K., & Tyler Davidson, J. (2024) · Forensic Chemistry · doi:10.1016/j.forc.2024.100605 · Cited by 20
Vandeputte, M. M., Bilel, S., Tirri, M., Corli, G., Bassi, M., Layle, N. K., Fantinati, A., Walther, D., Iula, D. M., Baumann, M. H., et al. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110113 · Cited by 19
The emergence of nitazenes: a new chapter in the synthetic opioid crisis
Caprari, C., Ferri, E., Rossetti, P., Gregori, A., Citti, C., & Cannazza, G. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04102-3 · Cited by 19
Vitrano, A., Giorgi, A. D., Abbate, V., Basile, G., Maida, N. L., Pichini, S., & Trana, A. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212332 · Cited by 19
Hollerbach, A. L., Lin, V. S., Ibrahim, Y. M., Ewing, R. G., Metz, T. O., & Rodda, K. E. (2024) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.4c00200 · Cited by 18
Interpol Review of Drug Analysis 2019-2022
Love, D., & Jones, N. S. (2023) · Forensic Science International Synergy · doi:10.1016/j.fsisyn.2022.100299 · Cited by 19
Gao, G., Yang, S., Wang, X., Xiang, P., Ma, L., Yan, F., & Shi, Y. (2025) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2025.116707 · Cited by 16
Identification of etazene (etodesnitazene) metabolites in human urine by LC‐HRMS
Verougstraete, N., Verhaeghe, A., Germonpré, J., Lebbinck, H., & Verstraete, A. G. (2023) · Drug Testing and Analysis · doi:10.1002/dta.3377 · Cited by 15
Testing for Protonitazene in Human Hair Using LC–MS-MS
Kintz, P., Ameline, A., Gheddar, L., Pichini, S., Mazoyer, C., Teston, K., Aknouche, F., & Maruejouls, C. (2024) · Journal of Analytical Toxicology · doi:10.1093/jat/bkae050 · Cited by 15
Magny, R., Schiestel, T., M’Rad, A., Lefrère, B., Raphalen, J.-H., Ledochowski, S., Labat, L., Mégarbane, B., & Houzé, P. (2025) · Metabolites · doi:10.3390/metabo15060371 · Cited by 14
“Etonitazene, first described in 1957, is, for instance, 100–1000 times more potent than morphine [3,4].”
InfluentialWachełko, O., Tusiewicz, K., Szpot, P., & Zawadzki, M. (2025) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2025.116796 · Cited by 14
Hardwick, E. K., & Davidson, J. T. (2025) · Drug Testing and Analysis · doi:10.1002/dta.3921 · Cited by 14
Maruéjouls, C., Ameline, A., Gheddar, L., Mazoyer, C., Teston, K., Aknouche, F., & Kintz, P. (2024) · International Journal of Legal Medicine · doi:10.1007/s00414-024-03309-w · Cited by 12
Computational design of dynamic biosensors for emerging synthetic opioids
Leonard, A. C., Lenert-Mondou, C., Chayer, R., Swift, S. D., Baumer, Z. T., Delaney, R., Friedman, A. J., Robertson, N. R., Seder, N., Wells, J. M., et al. (2026) · Nature Communications · doi:10.1038/s41467-025-67994-w · Cited by 12
“We focused on demonstrating urine ef fi cacy of the PYR1 nita sensors because these sensors recognize a R1 hydroxyl group present in metabolite products of common nitazenes 7,29 – 31 , thus enabling detection of nitazenes post-consumption.”
New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
Napoletano, S., Basile, G., Faro, A. F. L., & Negro, F. (2022) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v93i2.13008 · Cited by 12
The Future of Deadly Synthetic Opioids: Nitazenes and Their International Control
Lassi, N., & Jiang, S. (2025) · Global Policy · doi:10.1111/1758-5899.70000 · Cited by 9
Gundersen, P. O. M., Pasin, D., Slørdal, L., Spigset, O., & Josefsson, M. (2024) · Forensic Science International · doi:10.1016/j.forsciint.2024.112131 · Cited by 9
A novel screening workflow for nitazene analogs using LC–MS/MS precursor ion scan acquisition
Pacana, A. L., & Skillman, B. N. (2025) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaf046 · Cited by 8
Identification of nitazene‐related deaths in Australia: How do we make it accurate and timely?
Schumann, J. L., Dwyer, J., Brown, J. A., Jauncey, M., & Roxburgh, A. (2026) · Drug and Alcohol Review · doi:10.1111/dar.14028 · Cited by 7
Analytical approaches for the identification and quantitation of nitazenes: a review
Mandrioli, R., Protti, M., Lecce, R. D., & Mercolini, L. (2025) · Journal of Chromatography Open · doi:10.1016/j.jcoa.2025.100305 · Cited by 7
A case of fatal intoxication with the novel synthetic opioid N-pyrrolidino protonitazene
Wrbas, S., Sundermann, T. R., Auwärter, V., & Huppertz, L. M. (2025) · International Journal of Legal Medicine · doi:10.1007/s00414-025-03618-8 · Cited by 8
Behavioural Effects and Naloxone Effectiveness With New Synthetic Opioids
Nielsen, S., Silva, J. P., Jones, J. D., Krotulski, A., Poovendran, D., Muzangizi, D., Forte, G., White, J., & Comer, S. D. (2026) · Drug and Alcohol Review · doi:10.1111/dar.70040 · Cited by 6
Self-citationNalakath, J., Thacholil, R. P., Kadry, A., P, S., & Praseen, O. K. (2025) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.9982 · Cited by 6
Phelps, C., Hardwick, E. K., Couch, A. N., & Davidson, J. T. (2025) · Journal of Forensic Sciences · doi:10.1111/1556-4029.70084 · Cited by 6
Buratti, E., Mietti, G., Cerioni, A., Cippitelli, M., Froldi, R., Cingolani, M., & Scendoni, R. (2024) · Journal of Forensic and Legal Medicine · doi:10.1016/j.jflm.2024.102710 · Cited by 6
Protonitazene metabolite variability in postmortem casework
Wood, R., & Moore, R. (2025) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaf042 · Cited by 6
Detecting novel psychoactive substances around the world
Salomone, A., & Vincenti, M. (2024) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000939 · Cited by 6
“…and proactive approaches targeted detection and quantification of bror-phine [31] and nitazene analogues in biological samples are certainly needed [32,33], such a complex and alarming drug scenario requires the scientific community to make considerable efforts to improve NPS detection, possibly…”
Hataoka, K., Hojo, M., Nomura, S., Nakagawa, Y., Kawai, A., Nakamura, M., Ikushima, K., Alexander, D. B., Suzuki, J., Suzuki, T., et al. (2025) · The Journal of Toxicological Sciences · doi:10.2131/jts.50.33 · Cited by 5
Verbeek, J., & Brinkman, D. J. (2025) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70078 · Cited by 5
New and Emerging “Nitazene” Analogues Appearing in Medicolegal Death Investigations
Walton, S., Papsun, D. M., Shoff, E. N., Ellefsen, K. N., & Krotulski, A. J. (2025) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0000000000001025 · Cited by 5
Self-citationFerreira, C. F., Antunes, A. M. M., Gaspar, H., & Caldeira, M. J. (2025) · Forensic Chemistry · doi:10.1016/j.forc.2025.100696 · Cited by 5
Zhang, M., Feng, J., Chen, H., Xiang, P., Yan, H. F., & Zhao, J. (2025) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaf099 · Cited by 5
Bendjilali-Sabiani, J.-J., Eiden, C., Lossois, M., Martrille, L., Peyrière, H., & Mathieu, O. (2025) · Forensic Science International · doi:10.1016/j.forsciint.2025.112763 · Cited by 6
Akbaba, M., & Isır, A. B. (2025) · Applied Sciences · doi:10.3390/app15052267 · Cited by 7
Tomiyama, K.-I., & Funada, M. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117361 · Cited by 4
Fournié, C., Labat, L., Seigle, M. L., Mégarbane, B., Houzé, P., & Magny, R. (2025) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-025-06262-8 · Cited by 4
“Similar conclusions were reached by Walton et al. who analyzed 171 samples from 114 nitazene-poisoned patients in 2019–2021 [67].”
Chen, S., Aldabergenov, D., Alotaibi, K., Holland, A., Moore, R., Wood, R., Hudson, S. C., Milton, H., Menzies, E., Parks, C., et al. (2026) · Clinical Toxicology · doi:10.1080/15563650.2025.2601141 · Cited by 6
Toxicological aspects of emerging nitazene analogues as a new threat to the synthetic drug landscape
Martins, J. N., dos Santos, B. P., & Arbo, M. D. (2026) · Discover Toxicology · doi:10.1007/s44339-026-00050-4 · Cited by 4
“However, due to their potency, some nitazene analogues can generate pharmacologically active products, prolonging their effects on the body [4, 25].”
InfluentialTruver, M. T., Roman, M., Gomonit, M. M., Gréen, H., Kronstrand, R., & Persson, M. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04407-x · Cited by 4
Nitazene-related deaths in Norway 2021–2024
Vevelstad, M., Krabseth, H.-M., Haneborg, A.-M., Gundersen, P. O. M., Frost, J., & Øiestad, Å. M. L. (2026) · Forensic Science International · doi:10.1016/j.forsciint.2025.112794 · Cited by 3
Nalakath, J., Palathinkal, A. B., Naduvilakkandy, R., Vazhat, R. A., & Komathu, P. O. (2025) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.10111 · Cited by 3
Zhang, M., Chen, H., Tang, Y., Lin, M., Xiang, P., Yan, H. F., & Zhao, J. (2025) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.5c00081 · Cited by 4
Nitazenes Discharged during Super Bowl and Mardi Gras Celebrations in New Orleans, USA
Sapkota, R., Lomnicki, E. E., & Subedi, B. (2026) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.6c00010 · Cited by 3
Reversal of a synthetic opioid overdose: Insights from a validated translational model
Laffont, C. M., Purohit, P. G., de la Peña, A., & Skolnick, P. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110546 · Cited by 3
Tishion, P., Derrick, D., Sorrentino, J., & Cooper, G. A. A. (2025) · Journal of Forensic Sciences · doi:10.1111/1556-4029.70196 · Cited by 2
Pereira, J. R. P., Antunes, M., Neng, N. R., Mustra, C., Franco, J. M., & Fonseca, S. (2025) · Forensic Science International · doi:10.1016/j.forsciint.2025.112713 · Cited by 2
Taoussi, O., Carlier, J., Gameli, P. S., Huppertz, L. M., Bambagiotti, G., Tavoletta, F., Tini, A., Berardinelli, D., Busardò, F. P., & Auwärter, V. (2026) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-026-06472-8 · Cited by 2
Stang, B. N., Kent, J. T., Walton, S. E., Aldy, K., Culbreth, R. E., Falise, A. M., Campleman, S. L., Logan, B. K., Brent, J. A., Wax, P. M., et al. (2026) · Journal of Analytical Toxicology · doi:10.1093/jat/bkag036 · Cited by 2
Self-citationNegrault, N., Puech, B., Guyon, J., Daveluy, A., Bastard, S., Mete, D., & Maillot, A. (2025) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2025.01.096 · Cited by 2
Accidental protonitazene intoxication: clinical management and detection of a novel opioid
Meltzer, J., Boucher, A., Cohen, S., & Morere, J. (2025) · BMJ Case Reports · doi:10.1136/bcr-2024-261722 · Cited by 2
Krstenansky, J. L., Bacsa, J., & Zambon, A. C. (2023) · Journal of Forensic Sciences · doi:10.1111/1556-4029.15222 · Cited by 2
García, R. G., & López-Briz, E. (2023) · Revista Española de Drogodependencias · doi:10.54108/10040 · Cited by 3
The Nitazene Era: A Critical Turning Point in the Synthetic Opioid Crisis Beyond Fentanyl
Dow, L. F., Abisogun, A. A., Berida, T. I., Krishnan, S. C., Rathnayake, U., & Lindsley, C. W. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00696 · Cited by 3
Pardo, O., & Fernández, S. F. (2024) · Comprehensive analytical chemistry · doi:10.1016/bs.coac.2024.11.014 · Cited by 2
Analytical detection of New Psychoactive Substances in biological samples: a Systematic Review
dos Santos, M. G., Vescovi, V., & do Nascimento, R. J. A. (2025) · Revista Brasileira de Criminalística · doi:10.15260/rbc.v14i2.943 · Cited by 1
Hardwick, E. K., Couch, A. N., & Davidson, J. T. (2025) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.70004 · Cited by 1
“…characterization studies have shown, this substitution, as well as the presence of m/z 72.0813 (C 4 H 10 N + ; 0.0 mDa error) and m/z 44.0482 (C 2 H 6 N + ; − 1.8 mDa error), enables the identification of a di-ethyl substitution to the amine group of the core nitazene structure [37, 39, 43, 44].”
InfluentialPalathinkal, A. B., Basha, S. F., Laya, S., Nalakath, J., Komathu, P. O., Naduvilakkandy, R., Joseph, M., & Jose, S. V. (2025) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.70005 · Cited by 1
“Previous in vitro studies have identified several metabolites resulting from these transformations [27, 28].”
Kashindye, R. C., Yadav, D., & Yadav, R. (2026) · Journal of Forensic and Legal Medicine · doi:10.1016/j.jflm.2026.103069 · Cited by 2
Maxwell, M. K., Anwar, A. I., Hasoon, J., & Kaye, A. D. (2026) · Current Pain and Headache Reports · doi:10.1007/s11916-026-01525-0
“The structural differences in these analogs matter clinically because small chemical modifications alter potency, metabolism, and the ability of routine toxicology screenings to detect exposure [14].”
InfluentialDetermination of new psychoactive substances (NPS) in hair samples
Cabarcos-Fernández, P., & Barrera, A. M. B. (2024) · Comprehensive analytical chemistry · doi:10.1016/bs.coac.2024.10.010
Blood and derivatives in NPS detection: Current insights and future challenges
Rosendo, L. M., Simão, A. Y., Brinca, A. T., Barroso, M., & Gallardo, E. (2025) · Comprehensive analytical chemistry · doi:10.1016/bs.coac.2025.01.012
Nalakath, J., Nelliyott, I. W., Kadry, A. M., Sankar, K. K., & Parseen, O. K. (2025) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.10055
Yeni bir sentetik opioid protonitazen saptanan ölüm olgusu
Aksoy, U., Mutlu, E., & Çoban, İ. (2025) · The Bulletin of Legal Medicine · doi:10.17986/blm.1755
“2021 yılında ABD’de protonitazen ile 10, etodesnitazen ile 11 ve butonitazen ile ilişkili 3 ölüm vakası bildirilmiştir (22, 23).”
Difficulty in Detecting Opioid-Like Designer Drugs
Protti, M., Mandrioli, R., & Mercolini, L. (2026) · Springer eBooks · doi:10.1007/978-3-032-15015-8_15
Illicit opioid adulterant trends in patients presenting with acute opioid overdose
Levine, M. S., Culbreth, R. E., Buchanan, J., Schwarz, E., Love, J. S., Brent, J. A., Meaden, C. W., Judge, B. S., Aldy, K., Hendrickson, R., et al. (2026) · Journal of Analytical Toxicology · doi:10.1093/jat/bkag006
Self-citationKent, J. T., Culbreth, R. E., Lebin, J. A., Burkhart, K., Hendrickson, R. G., Dezman, Z. D. W., Aldy, K., Brent, J. A., Falise, A. M., Campleman, S. L., et al. (2026) · Journal of Medical Toxicology · doi:10.1007/s13181-026-01132-w
Self-citationOpioid-like designer drugs: A practical review of detection, confirmation and interpretation
Protti, M., Iattoni, C. P., Santos, H. M., Lodeiro, C., Capelo, J. L., Lecce, R. D., Mandrioli, R., & Mercolini, L. (2026) · Journal of Pharmaceutical and Biomedical Analysis Open · doi:10.1016/j.jpbao.2026.100112
Scully, L., Castle, J. W., Rago, M. D., de Boer, H. H., Schumann, J., Crump, K., Glowacki, L. L., & Gerostamoulos, D. (2026) · Metabolites · doi:10.3390/metabo16060358
“It is imperative that toxicology laboratories, public health officials, and policy makers remain vigilant and adaptable in their approaches to public safety and awareness regarding the continued emergence of potent NSOs.”
Determination of nitazenes in postmortem casework and their prevalence in the State of Maryland
Fagiola, M., & Phipps, R. (2026) · Journal of Analytical Toxicology · doi:10.1093/jat/bkag031 · Cited by 1
Upadhyay, N., Neel, L. T., Li, E., Silte, A. A., Lyu, R., Selley, D. E., Dewey, W. L., Zhang, Y., & Pagare, P. P. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00283
Tang, M., Zhang, Y., Hua, Z., Jia, W., Wang, N., Huang, B., Wang, H., & Cuimei, L. (2026) · Talanta · doi:10.1016/j.talanta.2026.130284
Niżnik, Ł., & Jurowski, K. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.112263
Souza, K. A. O., dos Santos, N. C. B. F., Lanaro, R., Walton, S. E., Krotulski, A. J., Logan, B. K., Yonamine, M., & Costa, J. L. (2026) · Drug Testing and Analysis · doi:10.1002/dta.70126 · Cited by 1
Self-citationAlcohol and Other Drug harm reduction literature review
Crossin, R., Ryder, B., Sims, E., & Whelan, J. (2026) · Otago University Research Archive (University of Otago)
Portable Electrochemical Screening of Nitazenes: A Proof-of-Concept for On-Site Forensic Detection
Vietti, S. E., Whoriskey, S., Allan, P., & Dennany, L. (2026) · ACS electrochemistry. · doi:10.1021/acselectrochem.6c00210
Zhu, S., Yu, D., Shi, X., Liu, Y., Zong, Y., Wu, N., Wang, N., Tong, G., Liu, Y., Zhang, H., et al. (2026) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2026.117762
Metadata
- Authors
- Walton, S. E., Krotulski, A. J., & Logan, B. K.
- Affiliations
- Thomas Jefferson University (US)
- Corresponding author
- Krotulski, Alex J
- Venue
- Journal of Analytical Toxicology
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-11-18
- Volume
- 46
- Issue
- 3
- Pages
- 221-231
- ISSN
- 0146-4760 (ISSN-L)
- 1945-2403
- PMC
- PMC8935987
- OpenAlex
- W3212915836
- Cited by
- 92
- References
- 9
- Citations by year
- 2026: 19 · 2025: 38 · 2024: 17 · 2023: 11 · 2022: 7
- FWCI
- 5.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Analytical Toxicology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- The Medicine Forum (submittedVersion, cc-by-nc)
- Funders
- National Institute of Justice (2020-DQ-BX-0007)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Physical Sciences › Chemistry › Analytical Chemistry › Analytical Methods in Pharmaceuticals
- Social Sciences › Law › Cybercrime and Law Enforcement Studies
- Keywords
- nitazenes, synthetic opioids, new psychoactive substances, isotonitazene, etonitazene, forensic toxicology, LC-MS/MS method development, multiple reaction monitoring, liquid-liquid extraction
- MeSH terms
- Analgesics, Opioid, Benzimidazoles, Chromatography, Liquid, Humans, Forensic Toxicology, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.